EMA — authorised 2 May 1996
- Marketing authorisation holder: N.V. Organon
- Status: approved
EMA authorised Urofollitropin on 2 May 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 2 May 1996.
N.V. Organon holds the EU marketing authorisation.